Natlawreview

Published October 6, 2026

Jupiter Neurosciences Announces First Patient Dosed in Phase 2a R

Read the full story at Natlawreview

Additionally, the Company's pipeline includes ALA-002, a next-generation, patented psychedelic ... press release . Jupiter's actual results could differ.